157 related articles for article (PubMed ID: 3838346)
1. Calcium and phosphate metabolism in children with idiopathic hypoparathyroidism or pseudohypoparathyroidism: effects of 1,25-dihydroxyvitamin D3.
Chan JC; Young RB; Hartenberg MA; Chinchilli VM
J Pediatr; 1985 Mar; 106(3):421-6. PubMed ID: 3838346
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism.
Okano K; Furukawa Y; Morii H; Fujita T
J Clin Endocrinol Metab; 1982 Aug; 55(2):238-43. PubMed ID: 6979550
[TBL] [Abstract][Full Text] [Related]
4. 1,25-dihydroxyvitamin D3-treated hypoparathyroidism: 35 patients years in 10 children.
Markowitz ME; Rosen JF; Smith C; DeLuca HF
J Clin Endocrinol Metab; 1982 Oct; 55(4):727-33. PubMed ID: 6896714
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia in children with disorders of calcium and phosphate metabolism during long-term treatment with 1,25-dihydroxyvitamin-D3.
Chan JC; Young RB; Alon U; Mamunes P
Pediatrics; 1983 Aug; 72(2):225-33. PubMed ID: 6688127
[No Abstract] [Full Text] [Related]
6. Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Mizunashi K; Furukawa Y; Miura R; Yumita S; Sohn HE; Yoshinaga K
J Clin Invest; 1988 Sep; 82(3):861-5. PubMed ID: 2843573
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
[TBL] [Abstract][Full Text] [Related]
8. Sigmoidal curve shift in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Mizunashi K; Furukawa Y; Goto MM; Abe K
Calcif Tissue Int; 1998 Apr; 62(4):290-4. PubMed ID: 9504951
[TBL] [Abstract][Full Text] [Related]
9. [Parathyroid insufficiency syndrome. Two new cases: type Ia pseudohypoparathyroidism and pseudo-idiopathic hypoparathyroidism].
Barajas de Frutos D; Pedrero Vera J; Bolívar Barrales JE; Espigares Martín R; Ortega Martos L; Vílchez Joya R; Bolívar Galiano V; Morell Bernabé JJ
An Esp Pediatr; 1989 Oct; 31(4):385-8. PubMed ID: 2560613
[TBL] [Abstract][Full Text] [Related]
10. 1alpha-hydroxyvitamin D3 in the long-term management of hypoparathyroidism and pseudohypoparathyroidism.
Lewin IG; Papapoulos SE; O'Riordan JL
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():203s-207s. PubMed ID: 606417
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.
Wang O; Xing XP; Meng XW; Xia WB; Li M; Jiang Y; Hu YY; Liu HC
Chin Med J (Engl); 2009 Feb; 122(3):279-83. PubMed ID: 19236804
[TBL] [Abstract][Full Text] [Related]
12. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
Kruse K; Kracht U; Wohlfart K; Kruse U
Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
[TBL] [Abstract][Full Text] [Related]
13. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A
J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700
[TBL] [Abstract][Full Text] [Related]
14. Hypoparathyroidism: Less Severe Hypocalcemia With Treatment With Vitamin D2 Compared With Calcitriol.
Streeten EA; Mohtasebi Y; Konig M; Davidoff L; Ryan K
J Clin Endocrinol Metab; 2017 May; 102(5):1505-1510. PubMed ID: 28324108
[TBL] [Abstract][Full Text] [Related]
15. Hypercalciuria associated with long-term administration of calcitriol (1,25-dihydroxyvitamin D3). Action of hydrochlorothiazide.
Santos F; Smith MJ; Chan JC
Am J Dis Child; 1986 Feb; 140(2):139-42. PubMed ID: 3753816
[TBL] [Abstract][Full Text] [Related]
16. Treatment of pseudohypoparathyroidism with 1 alpha-hydroxyvitamin D3.
Furukawa Y; Sohn H; Unakami H; Yumita S
Contrib Nephrol; 1980; 22():68-73. PubMed ID: 7398339
[TBL] [Abstract][Full Text] [Related]
17. 1 alpha,25-dihydroxyvitamin D3 corrects osteomalacia in hypoparathyroidism and pseudohypoparathyroidism.
Epstein S; Meunier PJ; Lambert PW; Stern PH; Bell NH
Acta Endocrinol (Copenh); 1983 Jun; 103(2):241-7. PubMed ID: 6687971
[TBL] [Abstract][Full Text] [Related]
18. Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in pseudohypoparathyroidism.
Yamamoto M; Takuwa Y; Masuko S; Ogata E
J Clin Endocrinol Metab; 1988 Mar; 66(3):618-25. PubMed ID: 2832440
[TBL] [Abstract][Full Text] [Related]
19. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
Chan JC; Lovinger RD; Mamunes P
Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
[TBL] [Abstract][Full Text] [Related]
20. [Transitory pseudohypoparathyroidism in the newborn infant].
Schaumberger E; Hohenauer L; Sommer R
Klin Padiatr; 1986; 198(4):349-52. PubMed ID: 3762009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
